Trials / Active Not Recruiting
Active Not RecruitingNCT05026827
Iyengar Yoga for Prolonged Grief Disorder
Iyengar Yoga as a Probe of Prolonged Grief Disorder Neurobiology
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Medical College of Wisconsin · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
Experiencing the death of a loved one is inevitable for older adults. Before the coronavirus disease 2019 (COVID-19) pandemic, over 2.5 million people died annually in the United States, including 52,000 in Wisconsin alone, and COVID-19 has added to this toll. Each person who dies leaves an average of five grieving people behind. Most grieving older adults are resilient and recover their pre-loss functioning within one year. However, in about 10%, acute grief becomes protracted and debilitating, leading to the development of prolonged grief disorder (PGD), a clinically diagnosable mental health condition. PGD in older adults increases the risk for poorer medical, mental health, and cognitive outcomes; lower quality of life; disability; premature mortality; and suicide. Despite the magnitude of this problem, the neurobiology of PGD in older adults is poorly understood. By using Iyengar Yoga (IY) as a probe for PGD neurobiology, this pilot project aims to address this critical gap.
Detailed description
Our goal is to conduct a pilot study to examine in PGD the modulating effects of 10-week IY on circulating endocannabinoid and emotion processing brain circuit, and the associations between biological changes and clinical response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Iyengar Yoga | Participation in Iyengar Yoga classes |
| OTHER | Socialization Control | Participation in socialization control group sessions |
Timeline
- Start date
- 2021-08-30
- Primary completion
- 2026-08-01
- Completion
- 2026-12-01
- First posted
- 2021-08-30
- Last updated
- 2026-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05026827. Inclusion in this directory is not an endorsement.